Edition:
India

Reckitt Benckiser Group PLC (RB.L)

RB.L on London Stock Exchange

6,170.00GBp
16 Aug 2019
Change (% chg)

90.00 (+1.48%)
Prev Close
6,080.00
Open
6,122.00
Day's High
6,178.00
Day's Low
6,121.00
Volume
870,333
Avg. Vol
1,401,614
52-wk High
7,174.00
52-wk Low
5,559.00

Latest Key Developments (Source: Significant Developments)

Reckitt Benckiser Partners With Founders Factory For JV
Monday, 5 Aug 2019 

Aug 5 (Reuters) - Reckitt Benckiser Group PLC ::RECKITT BENCKISER GROUP PLC - RB PARTNERS WITH FOUNDERS FACTORY AS EXCLUSIVE HYGIENE AND HOME INVESTOR.RECKITT BENCKISER - RB, FOUNDERS FACTORY HAVE LAUNCHED JV CALLED FOUNDERS FACTORY HYGIENE AND HOME.RECKITT BENCKISER GROUP PLC - START-UPS SELECTED FOR FOUNDERS FACTORY HYGIENE AND HOME TO HAVE ACCESS TO RB'S MARKET INSIGHTS INTO PRODUCTS.RECKITT BENCKISER - RB WILL INVEST IN A NUMBER OF "FAST-GROWTH" START-UPS SOURCED THROUGH FOUNDERS FACTORY'S GLOBAL NETWORK.  Full Article

Reckitt CEO Says No Plans To Divest Or Sell Scholl Business
Tuesday, 30 Jul 2019 

July 30 (Reuters) - Reckitt Benckiser Group PLC ::CEO SAYS NO PLANS TO DIVEST OR SELL SCHOLL BUSINESS.CEO SAYS "WE ARE VERY PREPARED FOR HARD BREXIT".CEO SAYS NO JOB CUTS PLANNED IN RELATION TO BREXIT.  Full Article

Reckitt Benckiser Says FY LFL Net Rev Target Revised To 2 to 3%
Tuesday, 30 Jul 2019 

July 30 (Reuters) - Reckitt Benckiser Group PLC ::H1 REVENUE ROSE 1 PERCENT TO 6.24 BILLION STG.FULL YEAR LFL NET REVENUE TARGET REVISED TO +2-3% (FROM +3-4%).LIKE FOR LIKE PERFORMANCE IN H1 WAS +1%, SOMEWHAT BELOW OUR EXPECTATIONS.FULL YEAR LFL NET REVENUE TARGET REVISION TO REFLECT SLOW START TO YEAR AND IMPROVING TRENDS FOR H2.HYGIENE HOME DELIVERED ANOTHER QUARTER OF CONSISTENT TOP LINE GROWTH BUT PROGRESS IN HEALTH IN Q2 WAS DISAPPOINTING.ARE FURTHER STEPPING UP INVESTMENT IN BEI AND MEDICAL MARKETING.EXPECT H2 TO BE BACK TO MORE NORMAL LEVEL OF GROWTH.RECKITT - WORK TO CREATE TWO STRUCTURALLY INDEPENDENT BUSINESS UNITS REMAINS ON TRACK FOR COMPLETION AROUND MID-2020.HY EPS 137.9 PENCE.HY ADJUSTED EPS 145.4 PENCE.TARGET OF MAINTAINING ADJUSTED OPERATING MARGINS IN 2019 REMAINS UNCHANGED..INTEND TO CONTINUE CURRENT POLICY OF PAYING AN ORDINARY DIVIDEND EQUIVALENT TO AROUND 50% OF TOTAL ADJUSTED NET INCOME.RECKITT BENCKISER GROUP - ADJUSTING EXPENSE IN RESPECT OF INDIVIOR PLC OF £867M (2018: £7M) IS REPORTED WITHIN DISCONTINUED OPERATIONS.RECKITT - SCHOLL CONTINUES TO DECLINE AS CO IMPLEMENTS PORTFOLIO RE-FOCUS OF BRAND, DETTOL & DUREX SLOWED IN SECOND QUARTER IN KEY DEVELOPING MARKETS.  Full Article

Reckitt Benckiser To Pay $1.4 Bln To Resolve All Federal Investigations
Thursday, 11 Jul 2019 

July 11 (Reuters) - Reckitt Benckiser Group PLC ::RECKITT BENCKISER GP - AGREEMENT TO RESOLVE ALL FEDERAL INVESTIGATIONS.RECKITT BENCKISER GROUP PLC - TERMS OF AGREEMENTS, RB WILL PAY A TOTAL OF UP TO $1.4 BILLION TO FULLY RESOLVE ALL FEDERAL INVESTIGATIONS.RECKITT BENCKISER GROUP PLC - SETTLEMENT AMOUNT WILL BE FUNDED THROUGH EXISTING BORROWING FACILITIES AND CASH GENERATION.RECKITT BENCKISER GROUP PLC - RB HAS A PROVISION OF $400 MILLION AND WILL INCREASE ITS PROVISION TO $1.5 BILLION AT ITS HALF-YEAR RESULTS.RECKITT BENCKISER GROUP PLC - BOARD OF RB DETERMINED THAT "AGREEMENT IS IN BEST INTERESTS OF COMPANY AND ITS SHAREHOLDERS".RECKITT BENCKISER GROUP PLC - RB BELIEVES PROVISION WILL COVER SETTLEMENT AND ANY REMAINING LITIGATION EXPOSURES.RECKITT - AGREEMENTS WITH U.S. DOJ, FTC TO RESOLVE INVESTIGATION INTO SALES AND MARKETING OF SUBOXONE FILM BY INDIVIOR.RECKITT BENCKISER GROUP - "BOARD OF RB DETERMINED THAT AGREEMENT IS IN BEST INTERESTS OF COMPANY AND ITS SHAREHOLDERS".RECKITT - SETTLEMENT IS NON-CRIMINAL RESOLUTION; ON BASIS THAT THERE IS NO ADMISSION OF VIOLATION OF LAW OR ANY WRONGDOING BY RB OR ANY RB EMPLOYEE.RECKITT BENCKISER GROUP - RESOLUTION WILL ALSO PROTECT GROUP'S PARTICIPATION IN ALL U.S. GOVERNMENT PROGRAMMES.  Full Article

Reckitt Chairman says CEO search "well underway"
Thursday, 9 May 2019 

May 9 (Reuters) - Reckitt Benckiser Group PLC ::RECKITT BENCKISER CHAIRMAN SAYS COMPANY CONTINUES TO ACTIVELY PURSUE M&A OPPORTUNITIES - AGM.RECKITT BENCKISER CHAIRMAN SAYS COMPANY IS "WELL UNDERWAY" WITH COMPREHENSIVE PROCESS TO SELECT CEO SUCCESSOR.RECKITT BENCKISER CHAIRMAN SAYS HOPEFUL COMPANY WILL BE ABLE TO NAME CEO SUCCESSOR IN "NOT TOO DISTANT FUTURE".  Full Article

Reckitt Benckiser Sees Improving Growth In Remainder Of Year After Slow Q1
Thursday, 2 May 2019 

May 2 (Reuters) - Reckitt Benckiser Group PLC ::Q1 TOTAL SALES 3,157 MILLION STG VERSUS 3,111 MILLION STG AS REPORTED A YEAR EARLIER.RB2.0 REMAINS ON TRACK..REMAIN ON TRACK FOR FULL YEAR NET REVENUE TARGET OF +3-4% LFL WITH GROWTH TO BE H2 WEIGHTED..EXPECT TO SEE IMPROVING GROWTH IN REMAINDER OF YEAR, PARTICULARLY IN H2.REITERATE 2019 TARGETS OF +3-4% LFL NET REVENUE GROWTH AND ADJUSTED(1) OPERATING MARGIN TO BE MAINTAINED.RECKITT BENCKISER, ON INDIVIOR/RB PHARMA-RELATED MATTERS, SAYS REMAINS INVOLVED IN ONGOING INVESTIGATIONS BY US DOJ, US FEDERAL TRADE COMMISSION.MAY INCUR LIABILITIES IN RELATION TO MATTERS RELATING TO INDIVIOR / RB PHARMA-RELATED LITIGATION MATTERS.ONGOING INVESTIGATIONS REFERS TO MATTERS RELATING TO RB PHARMACEUTICALS BUSINESS PRIOR TO ITS DEMERGER IN DECEMBER 2014 TO FORM INDIVIOR.FINAL COST ON RESOLVING INDIVIOR / RB PHARMA-RELATED LITIGATION MATTERS MAY BE SUBSTANTIALLY HIGHER THAN THIS PROVISION.  Full Article

Clorox Files False-Advertising Lawsuit Against The Maker Of Lysol
Thursday, 21 Mar 2019 

Clorox Co ::CLOROX FILES FALSE-ADVERTISING LAWSUIT AGAINST THE MAKER OF LYSOL.CLOROX - FILED LAWSUIT AGAINST RECKITT BENCKISER IN RESPONSE TO A WIDE-RANGING ADVERTISING CAMPAIGN FOR RB'S LYSOL BRAND.CLOROX - ACCORDING TO LAWSUIT, RECKITT BENCKISER'S CAMPAIGN IS DESIGNED TO "MISLEAD CONSUMERS TO PURCHASE" RECKITT'S PRODUCTS INSTEAD OF CO'S PRODUCTS.  Full Article

Petiq, Inc. Appoints Animal Health Executive Susan Sholtis As President
Wednesday, 19 Sep 2018 

Sept 19 (Reuters) - PetIQ Inc ::PETIQ, INC. APPOINTS PROVEN MULTINATIONAL ANIMAL HEALTH EXECUTIVE SUSAN SHOLTIS AS PRESIDENT.PETIQ INC - APPOINTED SUSAN SHOLTIS AS PRESIDENT, EFFECTIVE OCTOBER 1, 2018.PETIQ INC - SHOLTIS WILL SIMULTANEOUSLY RESIGN FROM HER DUTIES AS A MEMBER ON COMPANY'S BOARD.PETIQ INC - SHOLTIS HAS SERVED AS A GLOBAL MARKETING HEAD IN HEALTH DIVISION AT RECKITT BENCKISER SINCE 2017.  Full Article

Jab Holdings Cuts Stake To 2.97 Pct In Reckitt Benckiser
Wednesday, 8 Aug 2018 

Aug 8 (Reuters) - Reckitt Benckiser Group PLC ::JAB HOLDINGS B.V. CUTS STAKE TO 2.97 PERCENT FROM 3.68 PERCENT IN RECKITT BENCKISER GROUP PLC - FILING.  Full Article

Reckitt CEO bullish on consumer health, no comment on Pfizer
Monday, 19 Feb 2018 

Feb 19 (Reuters) - Reckitt Benckiser Group Plc ::RECKITT BENCKISER CEO SAYS NO COMMENT ON PFIZER CONSUMER HEALTH AUCTION.RECKITT BENCKISER CEO SAYS ACQUISITIONS MUST BE STRATEGICALLY COMPELLING, RB MUST BE A BETTER OWNER, AND MUST DRIVE VALUE FOR SHAREHOLDERS.RECKITT BENCKISER CEO SAYS CONFIDENT ABOUT GROWTH OF CONSUMER HEALTH CATEGORY IN LONG TERM.  Full Article

UPDATE 2-European shares crushed as Trump toughens stance on China

July 30 Europe's main STOXX 600 index posted its worst session since a selloff in May on Tuesday after U.S. President Donald Trump ramped up his trade rhetoric against China, deepening wounds left by a batch of weak economic data and corporate earnings.